Colombia Neglected Tropical Diseases Diagnosis Market Size & Outlook
Related Markets
Colombia neglected tropical diseases diagnosis market highlights
- The Colombia neglected tropical diseases diagnosis market generated a revenue of USD 195.7 million in 2024 and is expected to reach USD 289.5 million by 2030.
- The Colombia market is expected to grow at a CAGR of 7% from 2025 to 2030.
- In terms of segment, soil-transmitted helminthiases was the largest revenue generating disease in 2024.
- Chagas disease is the most lucrative disease segment registering the fastest growth during the forecast period.
Neglected tropical diseases diagnosis market data book summary
| Market revenue in 2024 | USD 195.7 million |
| Market revenue in 2030 | USD 289.5 million |
| Growth rate | 7% (CAGR from 2025 to 2030) |
| Largest segment | Soil-transmitted helminthiases |
| Fastest growing segment | Chagas disease |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
| Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
Other key industry trends
- In terms of revenue, Colombia accounted for 2.9% of the global neglected tropical diseases diagnosis market in 2024.
- Country-wise, Brazil is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil neglected tropical diseases diagnosis market is projected to lead the regional market in terms of revenue in 2030.
- Colombia is the fastest growing regional market in Latin America and is projected to reach USD 289.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neglected Tropical Diseases Diagnosis Market Scope
Neglected Tropical Diseases Diagnosis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DiaSys Diagnostic Systems | View profile | 101-250 | Holzheim, Rheinland-Pfalz, Germany, Europe | https://www.diasys-diagnostics.com/ |
| InBios | View profile | 51-100 | Seattle, Washington, United States, North America | https://inbios.com/ |
| ZeptoMetrix | View profile | 101-250 | Buffalo, New York, United States, North America | http://zeptometrix.com |
| Eurobio-Scientific | View profile | 51-100 | Essonnes, Ile-de-France, France, Europe | https://www.eurobio-scientific.com/ |
| Omega Laboratories | View profile | 101-250 | Mogadore, Ohio, United States, North America | https://www.omegalaboratories.com/ |
| Avacta Group PLC | View profile | 113 | Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, United Kingdom, LS23 7FA | https://www.avacta.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Oscar Health Inc Class A | View profile | 2400 | 75 Varick Street, 5th Floor, New York, NY, United States, 10013 | https://www.hioscar.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Colombia neglected tropical diseases diagnosis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 10.48% in 2024. Horizon Databook has segmented the Colombia neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of NTDs, especially Chagas disease, is a primary factor driving the overall market growth. Arauca and Norte de Santander are regions of Colombia that exhibit extremely high endemicity of mainly three NTD scutaneous leishmaniasis, Chagas disease, and leprosy.
According to WHO, in 2018, the incidence of leishmaniasis in Colombia was 53/100,000, out of which ~98% cases are of cutaneous leishmaniasis, and Chagas disease had an annual incidence of 11/100,000.
Reasons to subscribe to Colombia neglected tropical diseases diagnosis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Colombia neglected tropical diseases diagnosis market databook
-
Our clientele includes a mix of neglected tropical diseases diagnosis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Colombia neglected tropical diseases diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into Colombia neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Colombia neglected tropical diseases diagnosis market size, by disease, 2018-2030 (US$M)
Colombia Neglected Tropical Diseases Diagnosis Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
